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The prevalence of lymphoedema 
in women who attended an information 
and exercise class to reduce the risk of breast 
cancer-related upper limb lymphoedema
E. Jeffs1* and A. Purushotham2
Abstract 
Breast cancer-related upper limb lymphoedema (BCRL) affects approximately 20 % of women undergoing axillary 
intervention. Women who attended a “reducing your risk of lymphoedema” class, including exercise instruction, anec-
dotally reported positive BCRL outcomes. The aim of this study was to examine BCRL outcomes and perceived benefit 
for attendees at a “reducing your risk of lymphoedema” class between 2000 and 2005. A cross-sectional study was 
conducted in two parts: (1) self-report questionnaire regarding lymphoedema status and benefit received from class 
and exercise programme; (2) clinical evaluation and objective measurement to confirm BCRL. 46 women completed 
questionnaires; 40 continued to clinical evaluation and objective measurement. BCRL prevalence defined as ≥10 % 
excess limb volume was only 5 %, although clinician judgement identified 23 % with arm lymphoedema and 8 % with 
lymphoedema limited to the hand. Clinician judgement correlated highly with patient self-report (Kappa = 0.833, 
p = 0.000). All women found the class beneficial, reporting increased confidence to return to normal life and a wide 
range of activities/exercise. We conclude that prevalence of BCRL should be determined by both clinical judgement 
and objective measurement to avoid underestimation. The benefit of group education with a lymphoedema expert 
and of exercise instruction should be further explored, and the potential for exercise to reduce BCRL prevalence 
should be examined.
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Background
Lymphoedema is a common consequence of breast can-
cer treatment affecting approximately 20  % of women 
undergoing axillary intervention, with the majority 
developing swelling within 2  years (Disipio et  al. 2013). 
The impact of breast cancer-related upper limb lymphoe-
dema (BCRL) on the survivor is significant, including 
physical changes, impairment to function and daily life 
activities, challenges for work, social and leisure activi-
ties, and financial implications (Shih et  al. 2009; Carter 
1997; Fu 2008; Radina 2009). BCRL causes considerable 
psychological distress (Fu et al. 2013), and can alter body 
image and act as a visible reminder of breast cancer and 
its treatment (Vassard et al. 2010).
Women in the UK at risk of developing BCRL are rou-
tinely offered verbal and written advice regarding care 
and use of the arm (e.g. leaflets from Breast Cancer Care, 
Lymphoedema Support Network, Macmillan Cancer 
Support), with many services offering additional group 
education sessions. As part of a review of breast cancer 
care at our hospital we wished to explore the potential 
impact on BCRL outcome of a proactive approach to 
advice and education regarding exercise.
The role of exercise and movement to influence lym-
phatic and venous drainage is well recognised (Foldi 
and Foldi 2012; Lymphoedema Framework 2006; 
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International Society of Lymphology 2013). It is now 
accepted that appropriately performed exercise does not 
cause or exacerbate BCRL (Cheema et  al. 2014; Kwan 
et al. 2011; Stuiver et al. 2015). However, for many years 
women with and at risk of developing BCRL were advised 
to avoid any strenuous activity or exercise (Cemal et  al. 
2011; Lee et al. 2009; Nielsen et al. 2008), and many UK 
women still report precautionary behaviours; these 
include limiting use of their affected arm, and a desire 
for greater guidance regarding how to safely return to 
pre-treatment exercise and activity levels (anecdotal 
evidence).
We decided to review the outcomes of a group of women 
who had attended a “reducing your risk of lymphoedema” 
education and advice class (taught by author EJ) between 
2000 and 2005; to our knowledge, none of the women sub-
sequently reported development of BCRL. The class had 
included teaching of a simple exercise programme which 
had originally been developed by the author (EJ) in 2000 
at the request of women with BCRL who wanted to know 
how to safely return to pre-treatment exercise; they wished 
to recommence activities such as gym, playing tennis, golf, 
without triggering or exacerbating BCRL. So we wanted 
to know whether the “at risk” group had in fact achieved 
better lymphoedema outcomes than might be expected 
in such a group. Also, we knew that some women with 
established BCRL (n = 21) had used the bespoke exercise 
programme added to usual care and demonstrated a small 
but clinically and statistically significant greater reduction 
in excess limb volume (ELV) when compared to usual care 
alone (Jeffs and Wiseman 2013).
The primary objective of this study was to determine 
prevalence of clinically detectable BCRL in women who 
attended a “reducing your risk of lymphoedema” class 
between 2000 and 2005. In addition, we intended to 
observe how ELV and participant perception of BCRL 
compared with clinician assessment, so secondary objec-
tives included determining the number of women with 
ELV ≥10 % and patient-perceived BCRL, and the agree-
ment between all three methods. Finally, we wanted 
to know the patient-perceived benefit of attending the 
“reducing your risk of lymphoedema” class.
Participants and methods
The cross-sectional study was designed in two parts:
1. Self-report questionnaire to ascertain patient report 
of BCRL, and perceived benefit of attending the 
“reducing your risk of lymphoedema” class and 
undertaking the exercise programme;
2. Clinical assessment to confirm presence of BCRL 
and determine percentage ELV.
Participants
The participants were women who had attended a “reduc-
ing your risk of lymphoedema” class, taught by the author 
(EJ) at a London breast cancer support charity between 
2000 and 2005 (Jeffs 2006). The 1½ h class consisted of two 
parts: (1) explanation of BCRL, risk, and measures that may 
reduce risk of developing BCRL; (2) demonstration and 
practice of a simple 10–15  min exercise routine for daily 
home use. The exercise routine consisted of a proximal to 
distal sequence of deep breathing and gravity-resistive iso-
tonic arm exercises (flexibility and strengthening) designed 
to stimulate lymphatic and venous return. The class encour-
aged a return to pre-treatment exercise and activities at a 
time when women receiving breast cancer treatment in the 
UK were routinely advised not to lift more than 3 lb weight.
Records of the London breast cancer support charity 
were examined, identifying attendees at a total of 13 lym-
phoedema awareness classes (see Fig.  1). Women were 
excluded if they could not be contacted, were deceased, 
not well enough to participate, or had attended a class 
not taught by the author (EJ). As it was likely that, unbe-
knownst to the charity, some women were deceased or 
suffering from progressive disease (Cancer Research UK 
2015), we requested individual primary care providers 
(GPs) to confirm whether their patient was well enough 
to participate; 83 GPs (91 %) responded (see Fig. 1).
Data collection
In 2012, questionnaires were sent to 77 women with an 
explanatory letter, study information sheet, and stamped 
addressed envelope to return their completed question-
naire. One reminder letter was sent 6  weeks later with 
another copy of questionnaire and study information.
The questionnaire contained 27 items addressing three 
main areas: (1) breast cancer treatment; (2) develop-
ment of swelling and associated symptoms; (3) views on 
“reducing your risk of lymphoedema” class and perceived 
benefit of exercise programme. It combined tick boxes 
with free text and additional space for further comments. 
Receipt of completed questionnaire was considered con-
sent to part one of the study.
Each woman who returned a completed questionnaire 
was invited to attend for clinical assessment (study part 
two). One reminder letter was sent to those who did not 
respond or failed to attend a booked appointment.
Clinical assessment to determine the presence of BCRL 
followed the assessment method used in the author’s (EJ) 
clinical practice and previous research (Jeffs and Wise-
man 2013), addressing:
  • baseline demographics: age, weight, height, ethnicity, 
occupation, activity level;
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  • medical history: participant self-report of breast can-
cer treatment, current health status, onset and devel-
opment of swelling, precipitating factors, lymphoe-
dema precautions taken;
  • clinical examination of both limbs to determine pres-
ence of oedema;
  • participant perception of current arm symptoms: 
swelling, ache, heaviness, pain, numbness, tingling;
  • clinical measurements:
• limb volume, by Perometry, an infrared measuring 
device (Lee et al. 2011);
•  shoulder extension and abduction, using goniom-
etry (Jeffs and Wiseman 2013; Valentine and Lewis 
2006);
•  quality of life using LYMQOL, a lymphoedema-
specific arm questionnaire (Keeley et al. 2010);
•  self-report arm and hand function, using Quick-
DASH (Kennedy et al. 2013).
Examination of The London Haven database to identify women who, following treatment for breast cancer, 
attended a lymphoedema awareness class taught by author (EJ) between 2000-2005
(n=116, with 123 attendances)   
Study information sent to GP with request to 
know if patient well enough to participate. 
(n=91)
32 reminder letters sent to GP (35%). 
Information and invitation pack sent to 77
women.
Reminder letters sent to 33 women (43%).
Recruited to study part 1 (n=46)
46 (60%) completed questionnaires returned
Invitation posted re part 2, clinical assessment 
(n=46)
Data analysis (n=46):
46 questionnaires and 
40 clinical assessments 
Examination of NHS Summary Care Records to 
confirm contact details and current GP details  
(n=101)
Excluded (n=70)
22 deceased
8 address unknown/ 
gone away
6 no reply from GP
2 GP surgery closed
3 GP reports too unwell 
to participate
1 no axillary 
intervention
28 declined to participate
Clinical assessment completed (n=40) 
7 deceased
3 GP details could not 
be verified 
15 deceased
3 too unwell to 
participate 
3 no longer registered 
with GP surgery 
6 GP did not reply
2 GP surgery closed
2 addressee gone 
away 
6 returned blank form
(1=no axillary surgery)
23 no response 
Declined to participate in study part 2 
(n=6)
2 cancer recurrence
1 too far to travel
2 did not respond to invitation
1 failed to attend booked assessment
Fig. 1 Participant flow through trial
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Diagnosing lymphoedema
For the purpose of this study, the presence of BCRL was 
determined by three methods used in incidence and 
prevalence studies (Armer and Stewart 2005; Disipio 
et al. 2013; Hayes et al. 2008a):
1. clinician judgement, with the presence of one or 
more symptom of oedema regardless of severity: 
decreased visibility of veins, increased thickness of 
skin and subcutis, fullness of tissues or smoothing of 
natural limb contours, pitting oedema (Stanton et al. 
2006);
2. at least 10 % ELV, as measured by the Perometer;
3. patient self-report.
Analysis
Data were analysed to determine participant homoge-
neity and associations for diagnosis of lymphoedema by 
three methods: (1) clinical judgement, (2) objective limb 
volume measurement, (3) patient report. Sensitivity and 
specificity were calculated for method (1) versus (2) and 
(1) versus (3), with kappa statistics calculated for all 3 
methods as well as for each pair (Landis and Koch 1977).
Statistical analysis was carried out using SPSS version 
20 (IBM, USA), with significance set at p < 0.05.
Ethical issues
Approval was obtained from the National Research Eth-
ics Service (NRES Committee London-Dulwich) and 
sponsoring hospital’s Research and Development depart-
ment prior to commencement of the study. The study was 
conducted in compliance with the study protocol, ethi-
cal standards laid down in the 1964 Declaration of Hel-
sinki and Good Clinical Practice guidelines for research. 
All participants gave informed written consent prior to 
inclusion in the study.
Results
Forty-six women (60  %) completed questionnaires and 
40 women (52  %) underwent a clinical assessment, a 
conversion rate of 87 %. Demographic and clinical char-
acteristics for the 40 women (study part two) are shown 
in Tables 1 and 2. The only significant difference between 
women with and without clinician-determined lymphoe-
dema were ELV and duration of lymphoedema.
Lymphoedema prevalence
Nine women (23 %) had some degree of clinician-deter-
mined arm lymphoedema, which was also self-reported 
(see Table 3); four women (10 %) reported BCRL devel-
oped prior to attending the class. Only two women (5 %) 
reached the common diagnostic threshold of ≥10 % ELV, 
both of whom developed BCRL since attending the class. 
A further three women (8 %) had lymphoedema limited 
to the hand, also self-reported; thus the overall clinician-
determined prevalence of BCRL was 30 %. Another three 
women self-reported current lymphoedema which was 
judged by the clinician not to be BCRL: two women had 
bilateral hand oedema likely due to arthritis, and the 
third woman experienced only the sensation of swelling 
in an area of paraesthesia in her posterior upper arm.
A further twelve women (30  %) without any current 
symptoms reported previous experience of lymphoe-
dema affecting the hand, arm, axilla or breast; it is not 
known whether symptoms pre or post-dated attendance 
at the class. Eight women received lymphoedema treat-
ment which included hosiery; five women reported full 
resolution achieved within 1  month. Three of the four 
women who underwent sentinel node biopsy experienced 
transient oedema, which they did not consider to be lym-
phoedema as it spontaneously resolved within 1 month.
Of the six women (13  %) who completed question-
naires but did not attend the clinical assessment, three 
had reported current swelling which could not be veri-
fied, two reported swelling now resolved, and one had 
never experienced swelling.
Comparing diagnostic methods
The diagnostic method of ≥10 % ELV was 100 % specific 
(see Table  3) but had low sensitivity (17  %), identifying 
only two of the nine women with clinician-determined 
arm lymphoedema (k =  0.217, p =  0.029). There was a 
substantial level of agreement between clinician-deter-
mined swelling and patient self-report of current swelling 
(k = 0.833, p = 0.000, see Table 3).
Evaluating the “reducing your risk of lymphoedema” class 
and exercise programme
All 46 women (100  %) responding to the questionnaire 
found the class beneficial. They particularly valued access 
to a knowledgeable health care professional, evidence-
based information, specific advice regarding aspects 
of risk reduction and how to manage BCRL should it 
develop, the opportunity to share knowledge and expe-
riences with other women in the same situation. They 
firmly believed their increased knowledge helped to pre-
vent or minimise problems, supported their return to 
active daily life, and provided a strategy for self-manage-
ment of risk and any subsequent BCRL. Only five women 
(11  %) reported both benefit from increased knowledge 
and alarm from heightened awareness. Forty-five women 
(98  %) recommended similar sessions and information 
be made available to everyone undergoing breast cancer 
treatment; for example:
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Table 1 Demographic characteristics of total group and according to presence of clinician-determined BCRL
Characteristic Total group (N = 40) Lymphoedema present (N = 12) No current swelling (N = 28)
Age, years (median, LQ, UQ) 62 (55, 66) 62 (55, 68) 63 (55, 66)
Ethnicity, N (%)
 White British/White Other 35 (88) 9 (75) 26 (93)
 Black and minority ethnic 5 (13) 3 (25) 2 (7)
Employment, N (%)
 Professional/managerial 10 (25) 3 (25) 7 (25)
 Clerical/service/administration 7 (18) 3 (25) 4 (14)
 Skilled trade 2 (5) 1 (8) 1 (4)
 Manual 1 (3) 0 1 (4)
 Homemaker 2 (5) 0 2 (7)
 Retired 16 (40) 5 (42) 11 (39)
 Unemployed 1 (3) 0 1 (4)
 Missing 1 (3) 0 1 (4)
BMI (median, LQ, UQ) 26.05 (23.27, 27.95) 25.57 (24.16, 27.95) 26.50 (21.94, 28.22)
BMI, N (%)
 Normal (18.5–24.9) 15 (38) 4 (33) 11 (39)
 Overweight (25–29.9) 18 (45) 7 (58) 11 (39)
 Obese (≥30) 7 (18) 1 (8) 6 (21)
Time since surgery, months (median, LQ, UQ) 121 (110, 148) 130 (109, 152) 120 (112, 133)
Ipsilateral breast surgery, N (%)
 Wide local excision 19 (46) 6 (50) 14 (50)
 Mastectomy 12 (10) 2 (17) 8 (29)
 Mastectomy + reconstruction 9 (17) 4 (33) 6 (21)
Contralateral surgery, N (%)
 Wide local excision 2 (5) 1 (8) 1 (4) 
 Mastectomy 2 (5) 0 2 (7) 
Axillary surgery, N (%)
 Sentinel node biopsy/Sampling 4 (10) 0 4 (14)
 Axillary lymph node dissection 36 (90) 12 (100) 24 (86)
Radiotherapy, N (%)
 Breast only 25 (63) 7 (58) 18 (64)
 Breast and supra clavicular fossa 3 (8) 2 (17) 1 (4)
 Breast and axilla 4 (10) 1 (8) 3 (11)
 Breast, SCF and axilla 1 (3) 1 (8) 0
 None 7 (18) 1 (8) 6 (21)
Dominant side treated N (%)
 Yes 14 (37) 6 (50) 8 (29)
 Both sides 5 (12) 1 (8) 4 (14)
 No 21 (51) 5 (42) 16 (57)
Chemotherapy, N (%) 25 (63) 9 (75) 16 (57)
Hormone treatment, N (%) 30 (76) 6 (50) 8 (29)
Cellulitis, N (%) 9 (22) 3 (25) 6 (21)
Patient reported onset of oedema, months after 1st axil-
lary surgery (median, LQ, UQ)
7 (2, 12) 8 (6, 23) 5.5 (1.23, 12)
Patient reported onset of swelling, N (%)
 <3 months 8 (20) 2 (18) 6 (21)
 3–6 months 2 (5) 1 (8) 1 (4)
 >6 months 13 (33) 8 (67) 6 (21)
 Cannot remember 1 (3) 1 (8) 0
 Never developed lymphoedema 15 (38) 0 15 (54)
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* No significant differences between groups except for duration of swelling, p = 0.025
Table 1 continued
Characteristic Total group (N = 40) Lymphoedema present (N = 12) No current swelling (N = 28)
Reported trigger, N (%) 17 (43) 8 (67) 9 (32)
Received lymphoedema treatment, N (%) 20 (50) 11 (92) 9 (32)
Duration of swelling, months (median, LQ, UQ)* 102.5 (9.9, 129) 118 (96, 134) 54 (10.5, 108)
Table 2 Clinical characteristics of total group and according to presence of clinician-determined BCRL
Characteristic Total group (N = 40) Lymphoedema present (N = 12) No current swelling (N = 28) P
Clinical symptoms present, N (%)
 Decreased vein visibility 5 (13) 5 (42) 0
 Increased skin/subcutaneous thickness 4 (10) 4 (33) 0
 Fullness of tissues 15 (38) 12 (100) 3 (11)
 Pitting oedema 2 (5) 2 (17) 0
Patient reported symptoms, N (%)s
 Pain 9 (23) 3 (25) 6 (21)
 Ache 5 (13) 3 (25) 2 (7)
 Heaviness 8 (20) 4 (33) 4 (14)
ELV, ml (median, LQ, UQ) 1.5 (−63.5, 144) 120 (71.75, 171.75) −49 (−97, 105.5) 0.001
% ELV 0.07 (−3.14, 5.71) 4.81 (2.65, 8.51) −2.36 (−4.65, 3.47) 0.001
Limb volume difference (N = 39), N (%)
 <5 % ELV 27 (69) 6 (50) 21 (78)
 ≥5 < 10 % ELV 10 (26) 4 (33) 6 (22)
 ≥10 % ELV 2 (5) 2 (17) *1 pt not measured
Overall quality of life (LQ21 score) (best = 10, 
worst = 0)
8 (7.75, 9) 9 (8, 9) 8 (7, 9) 0.028
Physical domain (LQ F) (best = 10, worst = 40) 11 (10, 14) 12.5 (10.25, 14) 11 (10, 13) >0.05
Appearance/body image domain (LQ A) (best = 5, 
worst = 20)
5 (5, 6) 6.5 (5.25, 7.75) 5 (5, 5) 0.028
Symptoms domain (LQ S) (best = 6, worst = 24) 8.5 (7, 11) 10 (7, 12) 8 (7.25, 11.75) >0.05
Mood domain (LQ E) (best = 6, worst = 24) 10 (7, 11) 8 (7, 10) 10 (7.25, 11.75) >0.05
QD score (best = 0, worst = 99) 15.91 (5.11, 22.73) 18.18 (7.39, 22.73) 12.5 (4.55, 24.43) >0.05
Table 3 Level of agreement between clinically-determined lymphoedema and other methods
a Four women developed BCRL prior to attending the class
b Developed BCRL prior to attending the class
Clinical assessment data, n = 40 Clinical assessment by researcher Kappa
Lymphoedema  
present n = 12
No current lymphoedema  
n = 28
≥10 % ELV (whole arm) 2 0 0.217, p = 0.029
≥5 % ELV (whole arm) 6 6 0.278, p = 0.083
≥200 ml difference between arms 1 0
Patient self-report, n = 40
  Current arm swelling 9a 1b 0.833, p = 0.000
 Current swelling limited to hand 3 2
 Swelling resolved 0 12
 Never swollen 0 13
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“I hope that lymphoedema is taken more seriously 
by the medical establishment and that information 
& classes etc. now form part of a standard & holistic 
treatment plan” (ID38).
Most women (76 %) suggested the class should ideally 
be offered post-operatively; 25 women (54 %) suggested 
around 1 month and 11 women (24 %) suggested several 
months following surgery. Only 9 women (20  %) sug-
gested it was best offered preoperatively, although three 
women thought offering both pre and postoperative 
classes was preferable. Several women suggested indi-
vidual preference would affect the point at which both 
written information and class instruction would be most 
beneficial.
Thirty-seven women (80  %) reported benefit from 
being taught the exercise programme: 26 women (65 %) 
did the exercise programme for at least 1 month follow-
ing the class, with 13 women (33 %) continuing the pro-
gramme for at least 6 months (see Table 4). Some women 
reported still using the exercise programme whenever 
they became more aware of symptoms. Only one woman 
(2  %) stated the exercise programme was not helpful, 
although seven women (14  %) either could not remem-
ber the programme or recall whether it was beneficial. 
Twenty-nine women (63  %) indicated specific personal 
benefits, particularly increased confidence to know what 
they could safely do; the benefits include: 
“Relieve symptoms/aches and pains/tense muscles” 
(ID16,42,44), 
“Eased movement of arms” (ID31), 
“Gained strength in my arm” (ID40), 
“Stretching affected arm in all directions” (ID37), 
“I was able to see improvement” (ID46).
Many women wrote that they believed the knowledge 
they gained from the class helped to either prevent devel-
opment of lymphoedema or resolve any swelling that did 
develop; for example:
“Due to the exercises & other activities I’ve listed 
lymphoedema is minimum” (ID8);
“Probably the most useful session I attended post 
surgery. Helped me avoid lymphoedema” (ID23).
The women also wrote about gaining from the class 
and exercise programme confidence to return to normal 
Table 4 Reported precautionary behaviour and activities following lymphoedema awareness class
Characteristics Total group  
(N = 40)
Lymphoedema  
present (N = 12)
No swelling present
Swelling resolved  
(N = 13)
Never swollen 
(N = 15)
Lymphoedema precautions taken, N (%) 29 (73) 7 (58) 9 (69) 13 (87)
Frequency of exercise programme, N (%)
 Daily 25 (63) 9 (75) 9 (69) 7 (47)
 Several times/wk 5 (12) 1 (8) 2 (15) 2 (13)
 ≤Once per week 4 (10) 1 (8) 1 (8) 2 (13)
 Not done at all 1 (4) 0 0 1 (7)
 Cannot remember 5 (12) 1 (8) 1 (8) 2 (13)
Duration of exercise programme, N (%)
 6+ months 13 (33) 6 (50) 3 (23) 4 (27)
 3 < 6 months 7 (18) 1 (8) 3 (23) 3 (20)
 1 < 3 months 6 (15) 2 (17) 3 (23) 1 (7)
 1–4 weeks 1 (3) 0 0 1 (7)
 Cannot remember 9 (23) 3 (25) 2 (15) 4 (27)
 Missing 4 (10) 0 2 (15) 2 (13)
Current hobbies using affected hand/side 26 (65) 10 (83) 8 (62) 8 (53)
Current level of hand use
 Low 6 (15) 1 (8) 2 (15) 3 (20)
 Moderate 27 (68) 10 (83) 9 (69) 8 (53)
 High 7 (18) 1 (8) 2 (15) 4 (27)
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life and recommence a wide range of activities they might 
otherwise not have done. The exercise programme was 
used by some women as a bridge to other sports and 
exercise programmes; for example, following a return 
to Yoga or Pilates they gradually stopped doing the lym-
phoedema exercises. They reported a wide range of cur-
rent active sports and hobbies, including squash, tennis, 
golf, gym, body-building, pole-walking, kayaking. Ten 
women (22 %) reported employment or a regular hobby 
requiring repetitive hand and arm movements, includ-
ing pottery, glass-casting, mosaics, knitting, ceramics/
clay-throwing, painting, drawing, sewing, woodcarving, 
upholstering furniture. Although the majority were very 
active, five women (11 %) volunteered that they had cho-
sen to avoid or limit certain activities.
Discussion
Our finding of 5 % BCRL prevalence, defined as ≥10 % 
ELV, is lower than might be expected when compared 
with other cross-sectional studies similarly defining 
BCRL (Disipio et  al. 2013). When determined by clini-
cian judgement, we found 23 % prevalence of arm lym-
phoedema, which increased to 30  % prevalence with 
inclusion of lymphoedema limited to the hand, with a 
median 4.8 % ELV. In the absence of a definitive reference 
method for determining BCRL, it is difficult to determine 
whether a method is under or over-diagnosing lymphoe-
dema (Ward et al. 2015). However, we support the view 
that defining BCRL by limb volume difference underes-
timates the extent of the problem (Stanton et  al. 2006; 
Armer and Stewart 2005; Disipio et  al. 2013) and sug-
gest that clinical judgement should be included to ensure 
appropriate diagnosis.
Clinician-judgement is highly interpretive. We wanted 
to capture all cases of lymphoedema so there was no 
threshold for inclusion of clinical symptoms. However, 
diagnostic parameters used by clinicians in other stud-
ies were often not specified thus making any meaning-
ful comparison difficult (e.g. Hayes et al. 2008b; Ahmed 
2006; Schmitz et  al. 2010; Querci della Rovere et  al. 
2003). The challenge remains to quantify subjective diag-
nostic criteria to allow universal application and mean-
ingful comparison of findings.
Reported incidence/prevalence of BCRL varies widely, 
influenced by the definition of lymphoedema used and 
characteristics of different assessment methods (Armer 
and Stewart 2005; Disipio et al. 2013; Hayes et al. 2005; 
O’Toole et  al. 2013). Our study found that patient self-
report correlated highly with clinician judgement of 
BCRL, which supports the view that the patient report 
should also be considered when determining the pres-
ence of BCRL (Armer and Stewart 2005; Paskett et  al. 
2012). A tool to aid self-report diagnosis may well have 
reduced the overestimation of self-reported lymphoe-
dema (8 %) in our study (Armer et al. 2003; Norman et al. 
2001). Other objective measures such as bioimpedance 
ratios and limb volume change (using a pre-surgery base-
line) have been reported as beneficial in the early detec-
tion of lymphoedema (Perdomo et  al. 2014) but, in the 
absence of a definitive reference method, their precision 
as a diagnostic method have yet to be determined.
There is a developing body of evidence to support the 
safety and benefit of exercise for women with and at risk 
of developing BCRL (Box et al. 2002; Kilbreath et al. 2012; 
Schmitz et al. 2010; Lacomba et al. 2010); this informa-
tion this was not available at the time of the classes in 
2000–2005. There is now recognition of the importance 
of conditioning the limb to cope with day-to-day activi-
ties and emphasising what can and should be done, 
rather than adopting a precautionary and restrictive 
approach to daily activity (Miller 1998; National Institute 
for Health and Clinical Excellence 2014; Schmitz et  al. 
2009, 2010; Jeffs et al. 2015). Several studies have shown 
benefit from exercise instruction combined with edu-
cation about BCRL (Fu et  al. 2014; Sisman et  al. 2012). 
Group education about the importance of regular arm 
flexibility and strengthening exercises (in addition to gen-
eral activity and maintaining range of shoulder motion) is 
a relatively low-cost way to inform women about positive 
approaches to daily living with or at risk of developing 
BCRL, rather than merely advising what they can safely 
do.
Lymphoedema awareness sessions have the potential 
to empower women to live well and live normally fol-
lowing breast cancer treatment, and provide guidance 
regarding pacing of exercise and activities. Our findings 
highlight the great value women place on this opportu-
nity to gain evidence-based information and advice from 
a lymphoedema expert, with practical guidance to help 
them bridge the gap between post-operative exercises 
and various sporting activities and strenuous work roles. 
Women value expert information which increases their 
confidence to return to normal activity (Jeffs et al. 2015), 
but are frustrated by lack of information and poor quality 
or inaccurate information (Lee et al. 2010). In a study of 
136 women following breast cancer treatment, those who 
received information about lymphoedema experienced 
fewer lymphoedema symptoms (Fu et al. 2010), although 
no conclusions could be drawn about the optimal format 
of information provision.
The study was not designed to identify causality, how-
ever, we can speculate regarding possible reasons for 
the low prevalence of BCRL defined by ELV. The women 
believed the education and exercise programme were 
very beneficial, particularly with regard to information 
about actions to minimise or prevent BCRL symptoms. 
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Other factors will also have contributed to the BCRL out-
come, including provision of lymphoedema treatment; 
the majority of those who had experienced BCRL had 
received some form of lymphoedema treatment.
The combination of patient report, clinical assessment 
and objective measurement to determine prevalence 
provides a strong level of confidence in the findings. We 
achieved a reasonable response rate to the questionnaire 
(60  %) and a high conversion rate (87  %) to the assess-
ment phase; however, we do not know what happened 
to the 31 women (40 %) who did not return a completed 
questionnaire, nor were we able to confirm the self-
report of the six women who completed questionnaires 
(part 1) but did not attend the assessment (part 2). The 
study population included women whose attendance 
at the class had been recommended by the local breast 
cancer service, and also women who had actively sought 
out the lymphoedema awareness class following breast 
cancer treatment elsewhere in London and the UK; we 
did not collect information about the hospital where the 
women received their cancer treatment.
Our findings have led us to conclude that clinician-
judgement should be combined with objective measure-
ment of ELV to avoid underestimation of BCRL, and to 
detect mild arm lymphoedema and also lymphoedema 
limited to the hand; in addition, patient self-report should 
be taken into consideration. Further research should be 
conducted to determine the protective and treatment 
benefits of providing group education from a lymphoe-
dema expert and of teaching specific exercise; this is in 
addition to providing written information regarding lym-
phoedema care and general exercise.
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